SCHEMBL4769173

SCHEMBL4769173

CN1CCN(C(=O)c2ccc(-c3cc4c(Nc5cccc(Cl)c5)ncnc4[nH]3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.53
BTK Q06187 3/20 0.52
ABL1 P00519 2/20 0.51
BCR P11274 2/20 0.51
BRAF P15056 4/20 0.49
TNNI3K Q59H18 4/20 0.49
WDR5 P61964 1/20 0.47
KMT2A Q03164 1/20 0.47
TBK1 Q9UHD2 2/20 0.47
KIT P10721 2/20 0.46
MAPKAPK2 P49137 1/20 0.45
AURKB Q96GD4 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CNR1 P21554 1/20 0.44
CYP2C19 P33261 1/20 0.44
CNR2 P34972 1/20 0.44
TTBK1 Q5TCY1 1/20 0.44
TTBK2 Q6IQ55 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylpiperazine SCHEMBL4771183 0.96 RIPK1 (0.49) RIPK1BTKABL1BCRBRAF
SCHEMBL4773340 0.90 NPC1 (0.53) RIPK1BTKABL1BCRBRAF
SCHEMBL4352904 0.85 TTBK1 (0.51) ABL1BRAFTNNI3KCYP3A4CYP2D6
SCHEMBL4065929 0.83 RIPK1 (0.60) RIPK1BTKWDR5KMT2ATBK1
SCHEMBL7492081 0.83 EGFR (0.58) ABL1BRAFTNNI3KTTBK1TTBK2
SCHEMBL4766930 0.83 KDR (0.54) BTKABL1BCRBRAFTNNI3K
SCHEMBL7497707 0.82 BRAF (0.54) ABL1BRAFTNNI3KKMT2ACYP3A4
Hydrochloric Acid SCHEMBL4764268 0.82 KDR (0.54) BTKABL1BCRBRAFTNNI3K
SCHEMBL13604150 0.82 RIPK1 (0.61) RIPK1BTKWDR5KMT2ATBK1
SCHEMBL4766962 0.82 CYP1A2 (0.53) ABL1BRAFTNNI3KCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0938486-B1 SUBSTITUTED PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 2008-01-16 EP claimed
US-6180636-B1 USED TO INHIBIT THE TYROSINE KINASE ACTIVITY OF THE RECEPTOR FOR THE EPIDERMAL GROWTH FACTOR AND C-ERBB2 KINASE AND CAN BE USED AS ANTITUMOR AGENTS NOVARTIS AG (CH) 2001-01-30 US claimed
EP-0938486-A1 SUBSTITUTED PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION Novartis AG (CH) 1999-09-01 EP claimed
WO-1998007726-A1 SUBSTITUTED PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1998-02-26 WO claimed